This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
ALTHOUGH great progress has been made in the United States during the past two decades in detecting and treating hypertension and, as a result, reducing the disorders associated with it, more remains to be done.
In an effort to reduce the impact of hypertension even further a new group, the Coalition for Hypertension Education and Control, has been formed. The ultimate goal is not just improved control but disease prevention.
The new organization, introduced at a press conference in Washington, DC, is composed of the Association of State and Territorial Health Officers, National Medical Association, and National Council on the Aging. Two manufacturers of antihypertensive drugs, Lederle Laboratories, Wayne, NJ, and Procter & Gamble, Cincinati, Ohio, have also joined the coalition. In addition, the American Heart Association and the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, support the goals of the coalition.
Marwick C. Coalition Seeks Drop in Hypertensive Disorders. JAMA. 1994;271(15):1150. doi:10.1001/jama.1994.03510390014006
Customize your JAMA Network experience by selecting one or more topics from the list below.